- 201. ELEV TRANSAMINASE/LDH
- [ ] (UMLS (ICD9CM) C0159071) =Finding
| - 222. ELISPOT (enzyme linked immunospot assay)
- [ ] (UMLS (CSP) C0677645) =Laboratory Procedure ;
|
- 202. ELEVATE SKULL FX FRAGMNT
- [ ] (UMLS (ICD9CM) C0196118) =Therapeutic or Preventive Procedure
| - 223. Eliten
- [The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05) ( NCI )] (UMLS (NCI) C0733440) FOSINOPRIL SODIUM;
FOSINOPRIL SODIUM PREPARATION;
L-proline, 4-Cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy) propoxyl](4-phenylbutyl) phosphinyl]acetyl]-,Sodium Salt, trans- =Organophosphorus Compound; Pharmacologic Substance =FOSINOPRIL;
=FOSINOPRIL SODIUM 10 MG;
FOSINOPRIL SODIUM 20 MG;
FOSINOPRIL SODIUM 40 MG |
- 203. Elevated
- [An elevated level or position or degree; greater than normal in degree or intensity or amount. ( NCI )] (UMLS (NCI) C0205250) =Qualitative Concept
| - 224. ELIXIR
- [A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) ( NCI )] (UMLS (NCI) C0678430) =Biomedical or Dental Material =Oral Solution;
|
- 204. Elevated Bilirubin
- [Excessive concentrations of bilirubin in the blood, which may lead to jaundice. ( NCI )] (UMLS (NCI) C0311468) =Finding
| - 225. Elixophyllin
- (UMLS (NCI) C0700831) =Organic Chemical; Pharmacologic Substance
|
- 205. Elevated BP
- (UMLS (ICPC) C0497247) (Elevated BP; BIHOTZEKO PRESIO GORATUA HIPERTENTSIORIK GABE; Forhojet blodtryk (ex K86 K87); Verhoogde bloeddruk (ex K86 K87); KOHONNUT VERENPAINE (PL K86-87); Pression elevee (SF K86 K87); hoher Blutdruckwert (ex K86 K87); (108); emelkedett vernyomas(kiv.K86,K87); P.A.elevata(escl K86 K87); FORHOY BLODTRYKK EKS K86 K87; TA alta (excl K86 K87) ; Elevacion pa (ex K86 K87); FORHOJT BLTR (EXKL K86 K87)) Elevated BP (excl K86 K87); Elevated BP (excluding K86 K87) =Finding =CIRCULATORY; Diagnosis/Diseases Component
| - 226. Elk Valley Rancheria, California
- (UMLS (HL7) C1554299) =Population Group =NativeEntityContiguous;
|
- 206. Elevated prostate specific antigen [PSA]
- [ ] (UMLS (ICD9CM) C0178415) =Finding ;
| - 227. ELK1
- [ELK1 Protein is a member of the ELK subfamily of ETS DNA-binding transcription factors. (from OMIM 311040 and NCI) ( NCI )] (UMLS (NCI) C0209089) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 207. ELEVATED SEDIMENT RATE
- (UMLS (ICD9CM) C0151632) =Finding
| - 228. ELK1
- [This gene plays a role in transcriptional regulation and mediates DNA-binding interactions. The gene is also involved in MAP kinase signal transduction. ( NCI )] (UMLS (NCI) C0812446) ELK1 Gene;
ELK1, Member of ETS Oncogene Family Gene;
=Gene or Genome |
- 208. ELEVATED WBC COUNT NEC
- [ ] (UMLS (ICD9CM) C1719341) Other elevated white blood cell count =Finding
| - 229. ELK3
- [This gene is involved in B-cell development and immunoglobulin gene regulation. ( NCI )] (UMLS (NCI) C0812375) ELK3 Gene;
ELK3, ETS-Domain Protein (SRF Accessory Protein 2) Gene =Gene or Genome ;
|
- 209. Elevated white blood cell count
- (UMLS (ICD9CM) C0750426) WBC Increased;
White Blood Cell Count Increased;
=Finding | - 230. ELK3
- [ELK3 Protein, an ELK subfamily member of ETS-related DNA-binding transcription factors, is highly expressed at early stages of B-lymphocyte development, declining upon cell maturation. ELK3 may play a role in B-cell development and Ig gene regulation. (from OMIM 600247 and NCI) ( NCI )] (UMLS (NCI) C1321890) ELK3 Protein;
ELK3, ETS-Domain Protein;
ETS-Domain Protein;
ETS-Domain Protein ELK-3;
ETS-Related Protein;
ETS-Related Protein ERP;
ETS-Related Protein NET;
SAP-2;
SAP2 Protein;
SRF Accessory Protein 2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 210. Elevation
- [The condition of being elevated. ( NCI )] (UMLS (NCI) C0702240) =Spatial Concept ;
| - 231. Ellence
- (UMLS (NCI) C0701345) =Organic Chemical; Pharmacologic Substance ;
|
- 211. Eligibility
- [The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures. ( NCI )] (UMLS (NCI) C0013893) =Health Care Activity
| - 232. Elliotts B Solution
- (UMLS (NCI) C0059031) =Pharmacologic Substance ;
|
- 212. Eligibility Source
- (UMLS (HL7) C1550418) =Classification =HL7 Vocabulary Version 2.5;
=Insurance Company;
Employer;
Insured presented policy;
Insured presented card;
Signed statement on file;
Verbal information;
None | - 233. ellipse
- [An ellipse defined by four (column,row) pairs, the first two points specifying the endpoints of the major axis and the second two points specifying the endpoints of the minor axis. ( HL7V3.0 )] (UMLS (HL7) C1553440) =Intellectual Product =ROIOverlayShape;
|
- 213. EligibilityActReasonCode
- [Identifies the reason or rational for why a person is eligibile for benefits under an insurance policy or progam. Examples: A person is a claimant under an automobile insurance policy are client deceased & adopted client has been given a new policy identifier. A new employee is eligible for health insurance as an employment benefit. A person meets a government program eligibility criteria for financial, age or health status. ( HL7V3.0 )] (UMLS (HL7) C1699570) =Idea or Concept ;
=ActReason;
=CoverageEligibilityReason | - 234. Elliptocytosis
- (UMLS (NCI) C0427480) =Finding
|
- 214. Eligible
- [Insurance coverage is in effect for healthcare service(s) and/or product(s). ( HL7V3.0 )] (UMLS (HL7) C1548635) =Idea or Concept =Certification status;
ActCoverageEligibilityConfirmationCode | - 235. ELM
- [A plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma. ( MSH )] (UMLS (NCI) C0330531) =Plant
|
- 215. Eliminated
- [Taken out of, separated from, or eliminated. ( NCI )] (UMLS (NCI) C0849355) Out;
Removed;
Taken Out =Qualitative Concept | - 236. Elmiron
- (UMLS (NCI) C0600293) =Carbohydrate; Pharmacologic Substance ;
|
- 216. Elipten
- (UMLS (NCI) C0701949) =Organic Chemical; Pharmacologic Substance
| - 237. Elobromol
- (UMLS (NCI) C0878349) =Carbohydrate; Pharmacologic Substance ;
|
- 217. ELISA
- [immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase; while either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye; many variations of the method have been developed. ( CSP )] (UMLS (HL7) C0014441) =Laboratory Procedure =immunologic assay;
ObservationMethod | - 238. elongation factor
- [ ] (UMLS (CSP) C0086206) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 218. ELISA, antigen capture
- [ELISA, antigen capture ( HL7V3.0 )] (UMLS (HL7) C1553127) =Laboratory Procedure =ObservationMethod;
| - 239. Elongin Binding Protein
- [A product of the von Hippel Lindau tumor suppressor gene, Elongin Binding Protein (VHL) is a general transcription elongation factor that increases the rate at which RNA polymerase II transcribes DNA by suppressing polymerase pausing. VHL is part of a complex (VCB) that includes elongin B, elongin C, and cullin-2, proteins associated with transcriptional elongation and ubiquitination. VHL directly interacts with, and inhibits, SP1. VHL inhibits expression of hypoxia-inducing VEGF and GLUT1 genes. (from OMIM 193300 and NCI) ( NCI )] (UMLS (NCI) C0299505) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 219. ELISA, avidin biotin peroxidase complex
- [ELISA, avidin biotin peroxidase complex ( HL7V3.0 )] (UMLS (HL7) C0201697) =Laboratory Procedure =ObservationMethod;
| - 240. ELOXATIN
- (UMLS (NCI) C1135117) Eloxatine =Organic Chemical; Pharmacologic Substance
|
- 220. ELISA, peroxidase-antiperoxidase
- [ELISA, peroxidase-antiperoxidase ( HL7V3.0 )] (UMLS (HL7) C0201698) =Laboratory Procedure =ObservationMethod;
| - 241. Elspar
- (UMLS (NCI) C0699262) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
|
- 221. ELISPOT
- [ ] (UMLS (CSP) C0920508) enzyme linked immunospot assay =Laboratory Procedure
| - 242. Ely Shoshone Tribe of Nevada
- (UMLS (HL7) C1554300) =Population Group =NativeEntityContiguous;
|
home
